Low TSH with low free T4 indicates central hypothyroidism.

The biochemical diagnosis of hypothyroidism relies on the interplay between the pituitary gland and the thyroid. For a 58-year-old female, distinguishing between primary and central hypothyroidism is critical for identifying the underlying pathology and determining the appropriate clinical workup.

Clinical and diagnostic evidence

The biochemical hallmark of central hypothyroidism (CeH) is a low serum free thyroxine (FT4) level accompanied by a thyroid-stimulating hormone (TSH) concentration that is low, "inappropriately" normal, or only slightly elevated. This pattern directly contrasts with primary thyroid failure, where the pathology exists within the thyroid gland itself.

• Primary Thyroid Failure: Characterized by low FT4 and a markedly elevated TSH (typically >10 mIU/L), as the pituitary gland compensates for low hormone levels by increasing TSH production.
• Central Hypothyroidism: Characterized by low FT4 and a low or normal TSH, indicating that the pituitary (secondary hypothyroidism) or hypothalamus (tertiary hypothyroidism) is failing to respond to low peripheral thyroid levels.
• Diagnostic Sensitivity: While a low FT4 is nearly universal in overt CeH, TSH levels are within the laboratory reference range in approximately 25% to 75% of cases, though the TSH produced in these instances is often biologically inactive.

Mechanistic explanations

Central hypothyroidism is a failure of the hypothalamic-pituitary-thyroid (HPT) axis "underdrive."

• Hypothalamic/Pituitary Dysfunction: The condition arises from decreased secretion of thyrotropin-releasing hormone (TRH) from the hypothalamus or TSH from the anterior pituitary. This may be due to tumors (e.g., pituitary adenomas), trauma, or inflammatory conditions.
• Reduced Bioactivity: In many cases of CeH, the TSH molecules secreted have altered glycosylation patterns. While these molecules are detectable by standard assays (appearing "normal"), they possess significantly reduced biological activity, failing to stimulate the thyroid gland to produce T4.

Clinical implications

When this biochemical pattern is identified, it necessitates a shift in clinical focus from the thyroid gland to the brain.

• Secondary Testing: Identification of CeH requires further investigation into other pituitary axes (such as ACTH or growth hormone) and neuroimaging (MRI) to rule out structural lesions or mass effects in the sella turcica.
• Treatment Caution: In central hypothyroidism, TSH cannot be used to monitor the adequacy of thyroid hormone replacement. Treatment is instead titrated based on maintaining FT4 levels in the upper half of the reference range.

Bottom line

A low TSH combined with a low free T4 is consistent with central hypothyroidism resulting from hypothalamic or pituitary failure, rather than primary thyroid failure. This pattern indicates a breakdown in the central regulatory drive of the thyroid system.